Shah Nikita
SEC CIK 1738061 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | EVP | 253.4K | — | $7.57M | 31 | 2021-12-15 | 2026-08-12 |
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 16:22 | 2026-08-12 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $17.51 | -146.4K | 253.4K | -37% | -$2.56M | |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +508.5K | 182.6K | New | — |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $13.31 | -255.1K | 164.1K | -61% | -$3.40M |
| DM | 2025-11-14 | 2025-11-12 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | $2.75 | +131.9K | 182.7K | +259% | +$362.6K |
| D | 2025-11-14 | 2025-11-12 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale+OE | $11.92 | -131.9K | 146.4K | -47% | -$1.57M |
| M | 2025-08-25 | 2025-08-22+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $9.65 | -120.8K | 152.7K | -44% | -$1.17M |
| 2025-08-15 | 2025-08-14 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $9.29 | -71.7K | 267.2K | -21% | -$666.0K | |
| 2025-08-13 | 2025-08-12 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $9.04 | -50.0K | 338.9K | -13% | -$452.0K | |
| 2025-05-19 | 2025-05-16 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $7.58 | -49.1K | 388.9K | -11% | -$372.5K | |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +262.9K | 373.2K | +238% | — |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $8.77 | -134.5K | 349.7K | -28% | -$1.18M |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $8.67 | -11.0K | 309.6K | -3% | -$95.2K |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +29.0K | 320.6K | +10% | — |
| 2024-08-16 | 2024-08-14 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $7.75 | -100.0K | 291.7K | -26% | -$775.0K | |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +111.1K | 414.6K | +37% | — |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $5.47 | -56.3K | 350.7K | -14% | -$308.0K |
| D | 2024-02-29 | 2024-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $5.71 | -18.7K | 336.9K | -5% | -$106.6K |
| D | 2024-02-29 | 2024-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +35.6K | 355.6K | +11% | — |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +36.2K | 338.0K | +12% | — |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $1.92 | -18.1K | 320.0K | -5% | -$34.7K |
| DM | 2023-03-03 | 2023-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +40.7K | 317.4K | +15% | — |
| DM | 2023-03-03 | 2023-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $2.09 | -22.1K | 288.4K | -7% | -$46.1K |
| D | 2023-03-01 | 2023-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $2.16 | -19.8K | 283.2K | -7% | -$42.7K |
| D | 2023-03-01 | 2023-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +35.6K | 302.9K | +13% | — |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $3.40 | -2,228 | 267.3K | -0.8% | -$7,575 |
| D | 2022-05-10 | 2022-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +4,442 | 269.5K | +2% | — |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +40.7K | 274.0K | +17% | — |
| DM | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $4.45 | -12.5K | 265.1K | -5% | -$55.7K |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | M - OptEx | — | +35.6K | 248.6K | +17% | — |
| D | 2022-03-01 | 2022-02-27 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | F - Tax | $4.59 | -11.7K | 236.9K | -5% | -$53.7K |
| 2021-12-17 | 2021-12-15 | AMRX | Amneal Pharmaceuticals, Inc. | Shah Nikita | EVP | S - Sale | $3.95 | -2,000 | 213.0K | -0.9% | -$7,900 |
Purchase Sale Sale after option exercise All abbreviations